BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 29969732)

  • 1. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
    Zhang LX; Wei ZJ; Xu AM; Zang JH
    Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China.
    Zhu GS; Tian SB; Wang H; Ma MG; Liu Y; Du HS; Long YP
    Curr Med Sci; 2018 Feb; 38(1):78-84. PubMed ID: 30074155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
    Jia W; Yuan L; Ni H; Xu B; Zhao P
    Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.
    Pang W; Lou N; Jin C; Hu C; Arvine C; Zhu G; Shen X
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):493-502. PubMed ID: 26854795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma.
    Jiang K; Lei J; Chen W; Gong Y; Luo H; Li Z; Gong R; Zhu J
    Medicine (Baltimore); 2016 Oct; 95(40):e5079. PubMed ID: 27749581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva?
    Ertas IE; Gungorduk K; Akman L; Ozdemir A; Terek MC; Ozsaran A; Sanci M; Dikmen Y
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):138-42. PubMed ID: 23992992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios on Long-Term Survival in Patients with Operable Pancreatic Ductal Adenocarcinoma.
    Romano L; Giuliani A; Tomarelli C; Nervini A; Lazzarin G; Pessia B; Vicentini V; Carlei F; Schietroma M
    Med Princ Pract; 2022; 31(6):586-594. PubMed ID: 36323225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
    Wang X; Wang Z; Lu WL; Zhao GF
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
    Hirahara T; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Okubo K; Uenosono Y; Ishigami S; Natsugoe S
    BMC Cancer; 2019 Jul; 19(1):672. PubMed ID: 31286873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative platelet lymphocyte ratio is superior to neutrophil lymphocyte ratio to be used as predictive marker for lymph node metastasis in oral squamous cell carcinoma.
    Acharya S; Rai P; Hallikeri K; Anehosur V; Kale J
    J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27157628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer.
    Wu Y; Jiang M; Qin Y; Lin F; Lai M
    Clin Chim Acta; 2018 Jun; 481():20-24. PubMed ID: 29476736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.